Incidence, risk factors and management of delayed wound dehiscence after craniotomy for tumor resection.

J Clin Neurosci

Memorial Neuroscience Center, Memorial Hospital Jacksonville, 3627 University Boulevard South, Suite 355, Jacksonville, FL 32216, USA.

Published: June 2012

Dehiscence after a wound has healed is a known complication of craniotomy for tumor resection. We conducted a retrospective analysis of 64 patients who underwent craniotomy for tumor resection followed by radiation or radiosurgery between 2006 and 2010. Five patients (7.8%) were identified who showed wound dehiscence from two to eight months after the craniotomy wound had healed. Four patients had previously undergone additional craniotomies, additional radiosurgery or had been treated with the anti-angiogenic factor, bevacizumab. These treatments may be risk factors for developing delayed dehiscence and, in combination, may potentiate local wound healing problems. Potential mechanisms and management strategies are discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2011.09.025DOI Listing

Publication Analysis

Top Keywords

craniotomy tumor
12
tumor resection
12
risk factors
8
wound dehiscence
8
wound healed
8
wound
5
incidence risk
4
factors management
4
management delayed
4
delayed wound
4

Similar Publications

Putting the Puzzle Together: Case Report of Parinaud Syndrome in a Pediatric Patient.

J Binocul Vis Ocul Motil

January 2025

Department of Ophthalmology, Vanderbilt Eye Institute, Nashville, Tennessee.

Parinaud syndrome, also known as dorsal midbrain syndrome, is a condition affecting the dorsal midbrain region of the brainstem that presents with a triad of ophthalmic clinical findings, including upgaze paresis, convergence retraction nystagmus, and light-near dissociation. This case report will discuss the clinical presentation of Parinaud syndrome in a four-year-old patient who was seen in an out-patient clinic for intermittent exotropia 5 months after a suboccipital craniotomy resection of a pineal mass and ventriculoperitoneal (VP) shunt placement for associated hydrocephalus. Current literature is relatively sparse regarding the presentation of Parinaud syndrome in the pediatric population, with little known about prognosis and potential for recovery.

View Article and Find Full Text PDF

Objective: This study aimed to evaluate the efficacy and safety of bisphenol A-glycidyl methacrylate (bis-GMA) without UV light polymerization for the repair of refractory iatrogenic cerebrospinal fluid (CSF) leaks with large skull base defects.

Background: CSF leakage remains a common complication after neurosurgical interventions with a substantial resultant impact on morbidity and increased healthcare costs. The management of refractory CSF leaks with large skull base defects remains challenging.

View Article and Find Full Text PDF

 In this research, the authors provide a retrospective cohort study of 82 patients with suprasellar meningiomas to identify predictors of the visual outcome following surgery. We also conducted a matched retrospective case-control analysis.  This retrospective cohort study included all patients who underwent craniotomy for surgical excision of suprasellar meningiomas at our institution between January 2016 and March 2022.

View Article and Find Full Text PDF

Letter to the Editor Regarding "Safety and Efficacy of Ketorolac After Craniotomy for Tumor Resection".

World Neurosurg

January 2025

Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Lyari Hospital Rd, Rangiwara Karachi, Karachi City, Sindh.

To The Editor, We thoroughly read the article published in your journal entitled as "Safety and Efficacy of Ketorolac After Craniotomy for Tumor Resection" (1) and would like to appreciate the efforts being put by the authors. However to enhance the literature of this article we have some appraisal assessments which if added can enhance the quality of the literature and addressing these factors may improve the depth of the model.

View Article and Find Full Text PDF

Enhanced Recovery After Surgery (ERAS) is a recovery method developed to minimize pain and improve post-operative healing in patients. Brain tumor resection using the ERAS concept is relatively new. This case series evaluates the implementation of the ERAS protocol in three female patients diagnosed with supratentorial brain tumors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!